ArticlePharmacoEconomics2026
Beyond Narrative and Tabular Synthesis: Introducing an Approach-Rationale-Note (ARN) Framework for Thematic Evidence Synthesis in Economic Evaluation Reviews.
Article in PharmacoEconomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConventional evidence synthesis in systematic literature reviews (SLRs) of economic evaluations typically provides a narrative description of modelling approaches used across studies and rarely examines the underlying rationale for these choices or their interpretation. This study develops and applies a thematic synthesis approach to analyse modelling decisions reported in economic evaluations.
objectiveThe aim of this study was to introduce and apply an Approach-Rationale-Note (ARN) framework for thematic evidence synthesis in economic evaluation SLRs and demonstrate its application using economic evaluations of treatments for spinal muscular atrophy (SMA).
methodsEvidence from a previously conducted SLR of economic evaluations of SMA treatments was synthesised using a deductive thematic approach. The ARN framework structured the analysis by distinguishing modelling approaches, their rationales, and contextual observations relevant to interpretation. Analytical domains and dimensions were developed iteratively to enable comparison of modelling decisions across studies, with their selection guided by the review question and the methodological issues identified in the evidence base.
resultsSubstantial variation in modelling approaches was observed across key ARN domains, including model structure, health state definitions, treatment effect assumptions, extrapolation methods, and the handling of uncertainty. While several studies adopted similar modelling approaches, the rationales provided for these choices varied considerably. Health technology assessment (HTA) sources frequently highlighted uncertainty related to long-term outcomes, treatment durability, and survival extrapolation.
conclusionsA structured thematic synthesis of modelling decisions enables comparison not only of the approaches used in economic evaluations but also of the underlying reasoning behind those choices. The ARN framework provides a transparent and complementary approach for examining methodological decision making in economic modelling studies and may support improved interpretation of modelling assumptions in HTA and related evidence syntheses.
Identifiers
42754763What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.